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Percu taneous absorption of 4 rad iolabeled molecules was 
cOITlpared in the hairless rat (back) and in different anatomic 
sites in human (arm, abdomen, postauricular, forehead) . 
The conditions under which these 4 'co mpounds were ad-
ministered (area t reated, dose, vehicle, contact time, etc.) 
were similar in both species. T he results showed that, in 
hUITlans and rats, there exists the sa me rank order in total 
absorption: benzoic acid sodium sa lt < caffeine < benzoic 
acid < acety lsa licylic acid . In both species there was a fac tor 
of 3 between the mos t and the least abso rbed molecule . 
Altho ugh skin permeability varied signifi cantly with the 
physicochemical nature of the co mpound administered, it 
also depended on the anato mic site in vo lved . Independent 
of th e molecule studied, the rank order of permeability of 
W hcn rcvicwin g co mparative studics of percuta-nco us absorpt ion in hum ans and in anim als, we shou ld not o nl y qucs tion the anim al models , but also ask w hat influencc the methodology used may have had on the resul ts. This important 
ques tion is particularl y rcleva nt w hen data obta in cd fro m anim als 
are comparcd w ith dlOSC g ivcn for hum ans, and vicc vcrsa. It is 
diffic ul t, if not impossiblc, to distin guish bctwecn gcnuin c dif-
fcre n ccs duc to th c spccifi c morpho logic fcatu rcs of thc skin of 
cach spccies and thosc duc to thc vary ing tcchni qucs uscd. This 
is a strange situation , parti cul arl y as se veral principal expcrim cntal 
paralTletcrs affcctin g the absorption of a co mpound arc now known 
[1-4] and thus easil y co ntro ll cd. 
Th is study compares thc percutancous absorp tio n of 4 m ole-
cules, adm ini stcrcd in vivo in hum ans and in thc hairless rat, 
under idcn tica l conditi ons, and thu s g ivcs a partial answer to the 
co ntrovcrsia l question: Ca n anim als bc uscd as resca rch m odels 
for hu m ans? 
MATERIALS AN D METH ODS 
Pereu taneo us abso rption of 4 labeled compounds (N cw En gland 
Nuclear)-[ca rboxyl-"'C] ace tylsa li cylic acid (55 mCi/ mm ol, pu-
rity >98%), [ring- '4C] benzoic acid (50 m Ci/mmol, puri ty > 97%), 
[l - rneth yl-' <1C]caffeine (56 m C i/m m o l, purity > 98%), and Iring-
'4C]benzoic acid sodium sa lt (45 mCi/m m o l, purity > 97%)- was 
measured comparatively in the hairless rat (back) and in hum ans 
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the sites tested in humans appea red as follows: arm :S; ab-
domen < postauricular < fore head. There was a factor of 
3 between the most and the least perm eable sites. For each 
molecule and each anatomic site, the ratios of total per-
cutaneous absorption hum an/hairless rat (back) were de-
termined. For a given anatomic site and w hatever the mol-
ecule tested, these ratios were constant. It thus appea rs that 
when conditions are carefully controlled, it may be pos-
sible, by measurements on animals , to predict the absorp-
tion of a compound in humans. Further experimentation 
with chemicals of va ried physicochemical properties w ill 
be required for validation of the model. J ]rilles! Dennato/ 
'88:577-581, 1987 
in diffcrcnt anatomic sites (a rm , upper outer; abdomen; posta ur-
icul ar; forehcad). 
E ight fema le Sprague- Dawley hai rless rats (Iffa C redo , France), 
weightin g 200 :!:: 20 g w ere used for each moleculc. The tests on 
hum ans included 6-8 white m ale informed volun tecrs, aged 
28 :!:: 2, for each m olecule and each sitc. 
Application Conditions O ne thousand nano m olcs of cach 
molecule, w ith a spccifi c act ivity red uced at 10 - 3 ,uC i/ nm ol, wcre 
applicd to an area of 1 sq uare centimeter in 20 ,ul of a vehiclc, 
the co mpositio n of w hi ch was chosen accord in g to th c solubility 
of the substa ncc. Triton X -1 00 (Ro hm & H aas) was added as a 
surfacta nt to promote cvcn spreading of the vchi clc ovcr the 
trcated area, the boundaries of w hich were circumscri bed by an 
opcn circul ar ccll fixcd by sili conc g lue to prcven t chcmi ca l loss. 
After 30-min contact, in both hum ans and in rats, the surplus 
substance on th e area was rapidly removed by was hin g twice 
(2 x 300 ,ul) with a 95-5 mixture of ethano l-water, and then 
r insin g twice (2 X 300 ,u1) with distilled water, followed by light 
dryin g wi th cotton bud. 
Conditions of Measurement of Percutaneous Absorption 
III rhe Hairless Rat: At the cnd of applica tion and th e washin g 
procedures , the animals, wearing collars to prevent any con ta m-
in ation by lickin g, were placed in individu al metabolism cages 
for 4 days. Thc kinetics of urin ary excretion of th e substa nccs 
wcrc dctcrmined by liquid scintillation coun tin g (Packa rd 460 C, 
Packa rd In strum ents, U .S.A.) of thc urine prod uced dai ly durin g 
this pcriod . T hc feces wcre collected daily and pooled. Aftcr 
lyop hilization and homogeni za tion, sa mples wcre takcn and thcir 
rad ioactivity was measured by liquid scintillation countin g afte r 
com bustion (Oxid izer 306, Packard Instrum cnts). 
0022-202X/87/$03.S0 Copyri ght © 1987 by The Society fo r Investiga tive Dermatology, Inc. 
577 
578 ROUG IEH. LOTTE. AND MAl BACH T H E JO URNAL OF INV ESTIGATIV E DERMATOLOGY 
Table I. Kin eti cs o f Urin ary Excretio n of the Tested Mo lecules Fo llowin g Their Top ical Adm inist ra tion o n the 
Hairless Rat (Back) 
Urinary Excretion (nm ol' cl11 - 2) 
Co m pound 0- 24 HOllrs 24-4H Hours 4H-72 Hours 72-% Ho urs 0-% H ours 
I3cn zo ic ac id sod iulll sa lt 3.9 1 0.36 
(n.SH)" (0.03) 
Caffein e S.H I 0.72 
(0 .47) (0. 14) 
I3 cnzo ic acid 11 .24 0.75 
( 1.(,0) (0. 14) 
Acety lsa licy li c acid 6.47 2.94 
(O.(iO) (O.(i l ) 
"N um bers ill parentheses art.: SD. 
Afte r 4 days, th e rats were ki ll ed by ce rvica l dis loca tion. Six 
cell o phane tape strippings (3 M un vis ible ad hes ive tape) we re per-
fo rm ed o n the trea ted area to dete rmin e the am o unts of substa nce 
still present in the st ratum corn eum . T hese amou nts we rc di s-
co untcd in the tota l abso rpti on , not yet hav in g pcnctratcd. T he 
(J . I') 
(0.02) 
(J.3() 
(0. 12) 
0 .60 
(0. 13) 
2.32 
(0.34) 
O.3(J 
(O.OH) 
0.24 
(0. 10) 
0.3() 
(11.05) 
:US 
(1I.(i6) 
4.77 
(0 .60) 
7. 14 
(0.68) 
12.90 
(1.37) 
13.99 
( I . I '}) 
rem ainin g ski n (epidermis + dermis) of th e trea ted area was 
removcd, di ges ted (Solucnc 350, United Tcchn o logy Packard, 
U. S. A.), and rad ioacti vity asscssed by li quid scintillatio n CO Ullt-
in g after scintill ation cocktai l (Dim ilulll c 30, United Techn o logy 
Packa rd , U .S. A.) had been added. 
Table II. Percutaneo us Abso rpti on of the Tested M olecu les in fbt and in Humans Acco rdin g to An atomi c Site 
C o mpo und Spccies Anato mic Si te 
Bcnzo ic acid sodium Rat Ba ck 
salt, vehicle A 
Hum an Arm (upper, outer) 
Abdomen 
Posta uri cli lar 
Forehead 
Ca ffeinc, vehicle B Ibt Back 
Human Arm (upper, o uter) 
Abdo men 
Postauricular 
Forehead 
Benzoic acid , Rat Ba ck 
vehicle A 
Human Arm (upper. oute r) 
Abdo men 
Postauricular 
Forehead 
Acetylsali cy lic acid . Rat Back 
vehi cle A 
Hum an Arm (upper. outer) 
Abdo men 
Postauri cular 
Forehead 
Vehicle A : (c lhylcll eglycol/Tritoll X- lOO) (90/1 0) 
Vehicle 13: l(cthylcncglyco l/TritOll X- IOO) (90/ 10) 111 1-120 11 50/501 
{IExp ressed in 1111101/( 111 2 :Ipplication area . 
bFor hum an: :lIllOUlllS found in the firs t 24 h. 
' I' or hllm an: calculated va lues from (0). 
"SO . 
U rin e" 
4.77 
(0 .60),' 
3.02 
(0.34) 
5.73 
(0.54) 
7.54 
(0.62) 
9.31 
(1.76) 
7. 14 
(0 .6H) 
6.04 
(0.92) 
3.76 
(0.67) 
5.87 
(0.52) 
11.1 7 
( 1. 20) 
12.90 
( 1. 37) 
6.87 
(0 .75) 
10.88 
( 1. 23) 
16.87 
(3.85) 
20.1 0 
(2.39) 
13.99 
( 1.1 9) 
5.27 
(0. 18) 
5.34 
(1. 03) 
11.04 
(2 .50) 
10.89 
(1. 02) 
Tota l Amo un ts Found 4 Da ys After Top ica l Administration" 
Feces 
0.20 
(0.06) 
1. 13 
(0.23) 
0.63 
(0. 13) 
0.50 
(0. 13) 
Epidcrmis & 
Dermis 
T rca ted A rca 
0.46 
(0. 18) 
0.10 
(0.03) 
0.29 
(0.09) 
1 08 
(0. 13) 
Animal l30dy 
o 
fl.1 1 
(0.04) 
0.04 
(O.()1 ) 
o 
Tota l Penctration' 
5.43 
(0.77) 
4.02 
(0.45) 
7.65 
(0.72) 
10.05 
(0.82) 
12.32 
(2.30) 
8.48 
(0.88) 
12.09 
(1.84) 
7.53 
(1.34) 
11 .72 
( 1. 05) 
22.35 
(2.39) 
13.87 
(1.47) 
9 .1 5 
( 1. 0 1 ) 
14 .5 1 
(1.64) 
22.49 
(5.14) 
26.80 
(3. 19) 
15.57 
(1.22) 
17.00 
(0.37) 
17.20 
(3.35) 
29. 17 
(5.37) 
35. 14 
(3 .29) 
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T h e ca rcasses were lyo philized and homogenized , and the ra-
dioac tivity measured by liquid scin till ation countin g afte r co m-
bustio n. T he tota l amount of substa nce penetrating in 96 h was 
detc rmined by adding the amo unts found in the excreta (urin e 
+ fcces), in the ep idermi s and dermis of the treated arc;) and in 
the w hole an in131 body. 
III HUII/(/Ils: For techni c;) 1 co nveni ence, the mo lecules chosen 
were o nes eliminated q ui ckly and extensively in the urine. O n 
the b as is of prev io us data 15- 101 and o ur own res ults (Ta ble I) 
on th e k ineti cs of urinary excretion of these substa nces ad min-
istercd via V3 rious ro utes, in hum ans and in animals, the total 
amounts that penetrated w ithin 4 da ys were calculJted fro m the 
amounts excreted in the urin e in 24 h. T he latter accounted fo r 
0.75 , 0.50, 0.75, and 0.31 %, respectively, o f the tota l amounts 
of b e n zoic acid sodium sa lt, caffein e, benzoic acid , and acety l-
sa licy lic acid abso rbed. 
RESULTS 
The ki neti cs of urin ary excreti on of the co mpo un ds in the l13irless 
rat arc illustrated in Table I. With the exception of acety lsali cy li c 
acid, t he mo lecules studi ed were rapid ly elimin ated by this route. 
Twcn ty four-h o ur urin e contained, respective ly, 82, 81, and 87% 
of th e tota l amo un ts o f benzoic acid sodium salt , caffeine, and 
benzo ic acid excreted via the kidneys. 
Table II g ives the tota l urinary and feca l excreti on , reten tion 
in the bod y and in th e epidermis + dermis of the trea ted area , 
and the tot:ll penetrati on va lues of the mo lecules w ithin the 4 
days fo ll owi ng administrati on in the hairless ra t. N ote tlut, in-
dependcnt of the physicochemi cal pro perti es, includin g solubility, 
of thc molecul es tested , urin ary excretion acco unted fo r between 
86 and 96°;\, of tota l excretion (urin e + feces); practicall y none 
was r e tained in th e body . 
In humans, tota l abso rptio n o f the mo lecules ove r 4 days was 
calculated from the amo unts excreted in urine in 24 h (T3b le II ). 
Thc rcsults showed th3t in hum ans and rats, the rank o rde r o f 
tota l a bso rption of the mo lecules tested was the sa me: benzo ic 
acid sod ium sa lt < c3ffeine < benzoic acid < acety lsa li cy li c acid . 
In th e rat, and in humans irres pective of the anatomic site, there 
is a fac to r o f about 3 between the hig hest and lowest mo lecule 
abso rpti on. T here was also confirm ati on of previo us conclusio ns 
[8, 11 ] that sa lts do not penetrate as readil y as their correspo ndin g 
acids. T he results show, in the rat and hum ans, a facto r of 2 
betvvecn the absorpt io n level of benzoic 3cid and its sodium sa lt . 
Ju s t as cll ta neo us perm eability va ries substanti all y with the type 
of molecule administered, o ur results show that in humans it also 
depends on the anatomi c site. As a general rule, th e order of 
perm ea bili ty o f the sites studied is as follows: arm ~ abdo men 
< postauri cular < foreh ead. Furtherm ore, whatever the mo le-
cule, the forehead is 2-3 tim es more permea ble th an the arm or 
abdomen. T his o bse rvation confirms th ose made on the sa me 
sites w ith other molecules such as hydrocortisone [1 21. parathio n 
and lTlalathion [13]. Finall y, the hi gh permeability of the post-
auricular regio n, nea rl y the sa me as that of th e forehe ad , confirms 
tha t th is reg io n is a good pathway fo r transcutaneo lls pro phyla xis 
of motion sickness by sco po lamin e 11 4,15]. 
D ISC U SS IO N 
The a b so rptio n level of a mo lecule is kn own to be depend ent o n 
the conditi o ns ofappli c3tio n , w hich ma y p3rtl y ex plain the w idely 
varying results publi shed fo r the sa me chemi cal , ad mini stered to 
the same species . Amon g f3ctors th at can affect pe rcuta neoll s 
absorption , so me ca n eas il y be contro lled, slI ch as the sur f:lce area 
trea ted, the vehicl e 11 6-181, the applied dose 110, 19,201. the con-
tac t ti me [9, 16,21] . Other facto rs depend ing o n the fun ctio nal 
state of the skin barrier are presentl y beyo nd contro l. So, alth o ugh 
it is rel at ively easy to un derst3nd and even predi ct th e effe ct of 
alterin g the method o logy, it is 111 0 re diffi cult to find an expla-
natio n fo r th e differences o bse rved in the absorption of 3 CO I11-
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Figure 1. InAuenc~ of [h ~ 3n'Homic location on th ~ p~rcu[an~ou s pcnc-
tr:.tion of the tcs [~d molecules. 
po und between species o r between anato m ic sites in th e same 
species, as th ese depend on in timate differen ces in the phys io logy, 
ph ysicochcmistry, and /o r morph ology of the membrane that re-
main to be discove red. 
O ur results show that in humans, skin perm eabili ty va ries sig-
nifi ca ntl y acco rd in g bo th to th e nature of the co m poun d admin-
istered 3nd the anato mi c loca tion. Figure 1 simultaneously shows 
the influence of these [ Icto rs. The penetratio n va lues are expressed 
in rebtio n to th at of benzoic acid sodium sa lt ap plied o n the arm. 
It is es tablished tlut skin permea bility is mainl y co ntro lled by 
the stratum co rneum 122,23]. T ransport mechani sms, w hi ch are 
pass ive 123,24], sho ul d be govern ed by gcnerallaws of m embrane 
diffusion. T his ove rsimplistic approach to the tran spo rt phenom-
ena within the skin ca n , in o ur opi nio n, on ly be theo reti ca l and 
m 3Y no t apply to a ph ysicochemicall y highl y complex discontin-
uo us barrier, li ke th e ho rn y byer [1 2, 13,25]. In hum ans, for ex-
ample, irrespecti ve of the mo lecule tested, our resu lts show that 
the fore head is 2-3 times mo re pe rmea ble than the arm o r th e 
abdomen. o r th e back of the r3t , in spite of the similari ty in the 
thickness of th e st ratum corneulTl in th ese different sites (- 12-15 
J.Lm) 11 0,26-291. T he ho rn y layer thi ckness docs not, therefore, 
appea r to be a suffi cient ex planation of similariti es o r differences 
in th e absorptio n of the sa me mo lecule fro m one species to ano ther 
o r from one anato mic site to another in the sa ill e species. 
A recent hypothesis by E lias ct al [25,301 suggests that the 
stratum corneum in tercellular lipidic cemen ts may form a real 
ba rrier to the abso rptio n of substan ces. Va ri ati ons in th e CO Ill-
position of these ce ments could explain the differences in perme-
ability o bserved between species and between sites. 
A possible explanatio n fo r hi gher penetration levels in areas 
such as the fo rehead , w here there arc m o re sebaceous glands, 
could be that the abso rptio n occllrs thro ugh th e fo lli cles rather 
than throug h the epidermi s. However, it is not easy to reconcile 
the g rea t di sproportion (factor 50 to 100) existing ill the number 
of sebaceo us g lands between the arm and the fo rehead [31,321. 
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Table III. Ratios of Tota l Penetrati o n Values Human/Hairless Rat (Back) o f the Tested Molecul es Acco rdin g to 
Anatomic Site in Humans 
Tot;l l Absorption Ratios Hum an/ Hairless Ibt 
13cnzo ic Acid 
Anatomic Site in Hum ans Sodium Salt C arrcin c 
Arm (uppcr, o uter) 0.74 1.42 
(0. 19)" (0.36) 
Abdo men 1.4 1 U.89 
(U.33) (0 .25) 
Pos tauricubr 1. 85 1.38 
(0.4 1) (U.27) 
Forehead 2.27 2.63 
(0. 75) (0.55) 
"NullIbers ill parentheses arc SI), 
and th e relat ively sm all difference (fa ctor 2 to 3) obse rv ed in ski n 
permea bilit y between these two sites (Table II ). 
Moreover, apart from these purely morpholog ic considera-
ti o ns, from a physicochemica l vi ewpoint, it w o uld be possibl e to 
ass um e th at li pid- soluble substan ces mig ht diffu se preferentially 
through the sebaceous du ct, with the sebum acting as vehicle . 
However, T able II and Figure 1 show that there is th e sa me ratio 
(factor 2) in the permeability of areas rich in sebum , such as the 
fo rehead , and the arm where there is practica ll y no ne, to mole-
cules such as benzoic acid sodium salt o n one hand and benzo ic 
acid and acety lsalicylic acid o n the other, w hich arc radi call y 
o pposite in water- lipid solubi lity. 
Alth o ug h there is no doubt th at there arc substantia l differen ces 
in the absorpt io n of the same compound from one species to 
ano ther, it is diffi cult, o n the basis of the literature, to make a 
distin cti o n between true differen ces due to the specifi c structural 
and physicochemica l features of th e sk in of each species, and those 
simply due to the techniques used. Thus, most of the studies 
comparin g percutaneous absorption in humans and in animals 
have been based o n data in the literature, invo lvin g results from 
different teams often using va ried methodologies . 
As we attempted to do in this study, w hen the main parameters 
affecting absorption of a compound (surface area treated , dose, 
vehicle, applica tio n tim e, etc.) are carefully co ntro ll ed, th e on ly 
differences that appear are those that depend on the species, or, 
m o re subtly, on the anatomic site invol ved w ith in a species . For 
each m o lecul e and each site, the ratios of tota l percutaneous ab-
so rption human / hairless rat (back) w ere determined (Table III ). 
In o ppos ition to in vitro studi es, comparing skin permeability 
of human vs no tably hairless rat [33] or hairl ess mouse skin 134] 
to molecules of widely different physicochemica l properties, our 
resu lts show that, in vivo, for a given site in hum ans and whatever 
the m o lecule tested, these ratios are relatively constant. T his sug-
ges ts that w hen application conditions arc strictl y identi cal in 
humans and in anima ls, it may be possible to predi ct the in vivo 
abso rption of a chemica l in hum ans by measurements in anima ls. 
If this possibi lity is confirmed in other species and with other 
molecules, its co nsequences arc obvious and far reachin g . It would 
circum vent so me difficulties of hum an experiments, particul arl y 
with potenti all y tox ic compounds. It would also make it possible 
to screen new dru gs in animals and predict their toxicologic and/or 
pharmacolog ic implica tions in hum ans . Finally, from the view-
point o f basi c resea rch, animals co uld serve as faithful models for 
studi es of the mechanisms governing skin absorption in humans. 
Th e (l lIth ors ",ollld like 10 th allk A. M. Cabai/lot, C. Patolli/let, M. H . C rall -
didier, olld J. M(lcMastcr for their excel/wt tec/Illical assistoll ce. 
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